Results 291 to 300 of about 301,296 (304)

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

New England Journal of Medicine, 2009
Sebastian Schellong, Samuel Z Goldhaber, Sam Schulman   +2 more
exaly  

Thromboembolism is common and influences prognosis in patients with pancreatic cancer, study reports

Ca-A Cancer Journal for Clinicians, 2012
Mary Kay Barton
exaly  

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

New England Journal of Medicine, 2013
Peter Verhamme, Saskia Middeldorp, Harry Büller   +2 more
exaly  

Overweight, Obesity, and the Risk of Recurrent Venous Thromboembolism

Archives of Internal Medicine, 2008
Paul A Kyrle, Sabine Eichinger, Georg Heinze   +2 more
exaly  

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

New England Journal of Medicine, 2013
Sebastian Schellong, Samuel Z Goldhaber, Sam Schulman   +2 more
exaly  

Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism

JAMA - Journal of the American Medical Association, 2006
James Douketis, Alexander Turpie, Clive Kearon   +2 more
exaly  

Venous thromboembolic disease

Journal of the American Podiatric Medical Association, 1981
W B, Johnston, K R, Golda
openaire   +2 more sources

Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’

Annals of Oncology, 2012
Mario Mandala, Valter Torri, S Marsoni
exaly  

Prevention of venous thromboembolism

Progress in Cardiovascular Diseases, 1975
G P, Clagett, E W, Salzman
openaire   +2 more sources

Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality

American Journal of Obstetrics and Gynecology, 2006
Andra H. James, Leo R Brancazio
exaly